Early trials found that both garadacimab and sebetralstat were safe when used in patients living with hereditary angioedema, ...

Making clinical trials easier to find for clinicians and making protocols for entering clinical trials more lenient can help ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted.